Cumberland Pharmaceuticals (CPIX) Income from Discontinued Operations (2019 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Income from Discontinued Operations came in at -$1.2 million in Q2 2026, down 151.71% year-over-year from $2.3 million in Q2 2025, and down 151.71% quarter-over-quarter from $2.3 million in Q2 2025.
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Income from Discontinued Operations (2019 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Income from Discontinued Operations across 5 years of filings, most recently posting -$1.2 million for Q2 2026.
- In Q2 2026, Income from Discontinued Operations fell 151.71% year-over-year to -$1.2 million; the TTM figure through Jun 2026 stood at $1.1 million (down 51.71% YoY), while the FY2021 annual figure was $2.0 million, down 37.81% from the prior year.
- Income from Discontinued Operations came in at -$1.2 million for Q2 2026 at Cumberland Pharmaceuticals, down from $2.3 million in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of $2.3 million in Q2 2025 to a low of -$1.2 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | - |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | - |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 8.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | - |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | - |
| 10 | Cumberland Pharmaceuticals | 94.76 Mn | 90.90 Mn | - | -1.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.17 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Dec 31, 2021 | 503,318.00 |
| Sep 30, 2021 | 496,787.00 |
| Jun 30, 2021 | 498,807.00 |
| Mar 31, 2021 | 495,410.00 |
| Dec 31, 2020 | 872,064.00 |
| Sep 30, 2020 | 777,916.00 |
| Jun 30, 2020 | 738,622.00 |
| Mar 31, 2020 | 818,273.00 |
| Dec 31, 2019 | 2.40 Mn |
| Sep 30, 2019 | 1.35 Mn |
| Jun 30, 2019 | 771,709.00 |
| Mar 31, 2019 | 1.15 Mn |